Author of the publication

Effects of selective TNFR1 inhibition or TNFR2 stimulation, compared to non-selective TNF inhibition, on (neuro)inflammation and behavior after myocardial infarction in male mice

, , , , , and . Brain, behavior and immunity, 93 (March): 156-171 (2021)
DOI: 10.1016/j.bbi.2021.01.001

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Characterization of mouse cell line IMA 2.1 as a potential model system to study astrocyte functions, , , , , , , , and . Altex, 29 (3): 261--274 (2012)Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor, , , , and . Glia, 62 (2): 272--283 (February 2014)Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice, , , , , , , , , and 2 other author(s). PLOS ONE, 11 (10): e0163314 (2016)Ligand-induced internalization of TNF receptor 2 mediated by a di-leucin motif is dispensable for activation of the NFκB pathway, , , , , and . Cellular Signalling, 23 (1): 161--170 (2011)A TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell death, , , , , and . PLoS ONE, 6 (11): e27621 (2011)Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration, , , , , , , , , and 4 other author(s). Proceedings of the National Academy of Sciences, 113 (43): 12304--12309 (October 2016)Simvastatin interferes with process outgrowth and branching of oligodendrocytes, , , , , and . Journal of Neuroscience Research, 88 (15): 3361--3375 (2010)TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice, , , , , , , , , and 5 other author(s). Cell Death & Disease, 11 (3): 212 (2020)Antibody-mediated inhibition of TNFR1 attenuates disease in a mouse model of multiple sclerosis, , , , , , , , , and 2 other author(s). PLoS ONE, 9 (2): e90117 (February 2014)Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis, , , , , , , , , and 4 other author(s). Scientific Reports, (2018)